Search
for
Sort by
Research 931–960 of 1000+
- Hair growth is promoted by BeauTop via expression of EGF and FGF‑7
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Clinical Case Notes. Retinoblastoma, microphthalmia and the chromosome 13q deletion syndrome
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Hair Follicle Targeting with Nanoparticles
- Hereditary Hypotrichosis and Localized Morphea: A New Clinical Entity
- Anti-androgen therapy in dermatology: a review
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- A review of Janus kinase inhibitor use in scarring alopecia
- Cronkhite-Canada Syndrome: A Case Report
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Treatment options for alopecia areata
- Follicular Unit Hair Transplantation
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Alopecia areata: medical treatments
- Cytokines
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- Prognosis in patients with alopecia areata with poliosis: A retrospective cohort study of 479 cases
- Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- BCG'osis
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study